Related Experiment Video

Updated: May 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Statins in patients with chronic kidney disease: new evidence

M Savino1, C Garofalo, V De Paris

  • 1Nephrology, Seconda Università di Napoli, Naples, Italy - luca.denicola@unina2.it.

Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|July 23, 2013
PubMed

Insights

Dyslipidemia is common in chronic kidney disease (CKD). Statins effectively reduce cardiovascular risk in early CKD, while ezetimibe offers an alternative for intolerant patients across all stages.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Dyslipidemia is a frequent metabolic issue in chronic kidney disease (CKD).
  • Cardiovascular disease risk is significantly elevated in patients with renal impairment.
  • Inadequate cholesterol-lowering therapy is common in CKD patients despite high cardiovascular risk.

Purpose of the Study:

  • To review the role of cholesterol-lowering therapies in managing dyslipidemia in CKD patients.
  • To evaluate the efficacy and safety of statins and ezetimibe in different stages of CKD.

Main Methods:

  • Literature review of studies on dyslipidemia management in CKD.
  • Analysis of clinical trial data on statins and ezetimibe in renal impairment.
  • Assessment of cardiovascular risk reduction and tolerability profiles.

Main Results:

  • Statins are effective and safe for reducing cardiovascular risk in early-stage CKD.
  • Evidence for statin efficacy is limited in dialysis patients due to different cardiovascular mortality causes.
  • Ezetimibe is effective and well-tolerated for all CKD stages, especially for statin-intolerant patients.

Conclusions:

  • Statins are a key therapeutic option for early CKD dyslipidemia and cardiovascular risk reduction.
  • Ezetimibe provides a valuable alternative for managing dyslipidemia across all CKD stages, including dialysis.
  • Optimizing lipid management is crucial for improving cardiovascular outcomes in CKD.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...